SG11202004877UA - Sulfonamide compounds and use thereof - Google Patents
Sulfonamide compounds and use thereofInfo
- Publication number
- SG11202004877UA SG11202004877UA SG11202004877UA SG11202004877UA SG11202004877UA SG 11202004877U A SG11202004877U A SG 11202004877UA SG 11202004877U A SG11202004877U A SG 11202004877UA SG 11202004877U A SG11202004877U A SG 11202004877UA SG 11202004877U A SG11202004877U A SG 11202004877UA
- Authority
- SG
- Singapore
- Prior art keywords
- sulfonamide compounds
- sulfonamide
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762592023P | 2017-11-29 | 2017-11-29 | |
| PCT/IB2018/059430 WO2019106579A1 (en) | 2017-11-29 | 2018-11-28 | Sulfonamide compounds and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202004877UA true SG11202004877UA (en) | 2020-06-29 |
Family
ID=66665441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202004877UA SG11202004877UA (en) | 2017-11-29 | 2018-11-28 | Sulfonamide compounds and use thereof |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20200361883A1 (en) |
| EP (1) | EP3717462B1 (en) |
| JP (1) | JP6846574B2 (en) |
| KR (1) | KR102480074B1 (en) |
| CN (1) | CN111386260B (en) |
| AU (1) | AU2018377036B2 (en) |
| BR (1) | BR112020010148A2 (en) |
| CA (1) | CA3084030C (en) |
| MA (1) | MA51224A (en) |
| MX (1) | MX2020005478A (en) |
| PH (1) | PH12020550703A1 (en) |
| SG (1) | SG11202004877UA (en) |
| TW (1) | TWI762743B (en) |
| WO (1) | WO2019106579A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3466934T3 (en) | 2016-05-31 | 2024-04-23 | Taiho Pharmaceutical Co Ltd | Sulfonamide compounds or salt thereof as ribonucleotide reductase inhibitors for treating cancer |
| WO2018187479A1 (en) | 2017-04-04 | 2018-10-11 | Case Western Reserve University | Method of modulating ribonucleotide reductase |
| WO2022187200A1 (en) * | 2021-03-02 | 2022-09-09 | Boundless Bio, Inc. | Ribonucleotide reductase (rnr) inhibitors and uses thereof |
| CA3231660A1 (en) * | 2021-09-17 | 2023-03-23 | Anthony B. Pinkerton | Cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof |
| WO2023043938A1 (en) * | 2021-09-17 | 2023-03-23 | Boundless Bio, Inc. | Sulfamide ribonucleotide reductase (rnr) inhibitors and uses thereof |
| WO2024059563A1 (en) * | 2022-09-13 | 2024-03-21 | Boundless Bio, Inc. | Cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69909747T2 (en) * | 1998-02-09 | 2004-04-15 | Enzon Pharmaceuticals, Inc. | PHARMACEUTICAL COMPOSITION, CONTAINING PEG-ASPARAGINASE, FOR THE TREATMENT OF HIV INFECTIONS |
| AU1182300A (en) * | 1998-11-17 | 2000-06-05 | Fuji Photo Film Co., Ltd. | Bisaryl compounds and cancer remedies containing the same |
| CA2346063A1 (en) | 1999-08-06 | 2001-02-15 | Vassilios L. Avramis | Composition and methods for treatment of hiv infection |
| TW200637870A (en) * | 2005-01-31 | 2006-11-01 | Taiho Pharmaceutical Co Ltd | Novel pyrimidine nucleoside compound and salt thereof |
| TW200736234A (en) | 2006-01-17 | 2007-10-01 | Astrazeneca Ab | Chemical compounds |
| WO2007089018A1 (en) | 2006-02-03 | 2007-08-09 | Taisho Pharmaceutical Co., Ltd. | Triazole derivative |
| FI3466934T3 (en) * | 2016-05-31 | 2024-04-23 | Taiho Pharmaceutical Co Ltd | Sulfonamide compounds or salt thereof as ribonucleotide reductase inhibitors for treating cancer |
-
2018
- 2018-11-28 CN CN201880075992.0A patent/CN111386260B/en active Active
- 2018-11-28 TW TW107142471A patent/TWI762743B/en active
- 2018-11-28 MX MX2020005478A patent/MX2020005478A/en unknown
- 2018-11-28 JP JP2020529618A patent/JP6846574B2/en active Active
- 2018-11-28 BR BR112020010148-6A patent/BR112020010148A2/en unknown
- 2018-11-28 US US16/768,031 patent/US20200361883A1/en active Pending
- 2018-11-28 MA MA051224A patent/MA51224A/en unknown
- 2018-11-28 AU AU2018377036A patent/AU2018377036B2/en active Active
- 2018-11-28 SG SG11202004877UA patent/SG11202004877UA/en unknown
- 2018-11-28 CA CA3084030A patent/CA3084030C/en active Active
- 2018-11-28 WO PCT/IB2018/059430 patent/WO2019106579A1/en unknown
- 2018-11-28 KR KR1020207018727A patent/KR102480074B1/en active IP Right Grant
- 2018-11-28 EP EP18882854.5A patent/EP3717462B1/en active Active
-
2020
- 2020-05-26 PH PH12020550703A patent/PH12020550703A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20200096261A (en) | 2020-08-11 |
| PH12020550703A1 (en) | 2021-04-26 |
| KR102480074B1 (en) | 2022-12-21 |
| RU2020121153A (en) | 2021-12-29 |
| AU2018377036A1 (en) | 2020-06-18 |
| BR112020010148A2 (en) | 2020-10-13 |
| CA3084030A1 (en) | 2019-06-06 |
| AU2018377036B2 (en) | 2022-04-14 |
| TW201925182A (en) | 2019-07-01 |
| EP3717462A4 (en) | 2021-07-21 |
| EP3717462B1 (en) | 2024-01-03 |
| WO2019106579A1 (en) | 2019-06-06 |
| JP6846574B2 (en) | 2021-03-24 |
| CN111386260B (en) | 2024-04-30 |
| US20200361883A1 (en) | 2020-11-19 |
| CN111386260A (en) | 2020-07-07 |
| MA51224A (en) | 2020-10-07 |
| TWI762743B (en) | 2022-05-01 |
| RU2020121153A3 (en) | 2021-12-29 |
| CA3084030C (en) | 2023-03-21 |
| EP3717462A1 (en) | 2020-10-07 |
| JP2021504432A (en) | 2021-02-15 |
| MX2020005478A (en) | 2020-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273236A (en) | Pyrazolopyrimidinone compounds and uses thereof | |
| IL264258B (en) | Substituted diazahetero-bicyclic compounds and their use | |
| SG11202004877UA (en) | Sulfonamide compounds and use thereof | |
| GB201818605D0 (en) | Nivel use | |
| GB201714745D0 (en) | New compounds and uses | |
| GB201714740D0 (en) | New compounds and uses | |
| GB201714734D0 (en) | New compounds and uses | |
| IL292488B1 (en) | Pyridinamine-pyridone and pyrimidinamine-pyridone compounds | |
| IL277502A (en) | Compounds and uses thereof | |
| IL279483A (en) | Cyanotriazole compounds and uses thereof | |
| GB201714736D0 (en) | New compounds and uses | |
| IL265531A (en) | N 3 -cyclically substituted thienouraciles and use thereof | |
| IL269836B (en) | Substituted n-arylethyl-2-aminoquinoline-4-carboxamides and use thereof | |
| IL292482B1 (en) | Azaindolylpyridone and diazaindolylpyridone compounds | |
| GB201712110D0 (en) | New compounds and uses | |
| GB201700404D0 (en) | Compounds and composistions | |
| IL269843B (en) | Substituted n-arylethyl-2-arylquinoline-4-carboxamides and use thereof | |
| GB201707846D0 (en) | Use | |
| IL265617B (en) | 1-phenylpropanone compounds and use thereof | |
| GB201720092D0 (en) | New Compounds and uses | |
| GB201719327D0 (en) | New compounds and uses | |
| GB201719233D0 (en) | New compounds and uses | |
| GB201712049D0 (en) | Novel compounds and their use | |
| GB201714743D0 (en) | New compounds and uses | |
| GB201718676D0 (en) | New use |